Trial Condition(s):

Hypertension

COugh among hypertensive patients treated with telmisartan, who had to stop previoUs ACE-i treatment due to couGH in Slovakia (COUGH)

Bayer Identifier:

15379

ClinicalTrials.gov Identifier:

NCT01217879

EudraCT Number:

Not Available

Study Completed

Trial Purpose

In the light of ONTARGET and TRANSCEND studies results, it would be interesting to investigate the real-life telmisartan treatment tolerability. It is well known and accepted that the Real-life setting is much more adequate to reflect the antihypertensive and safety properties of the drug in comparison to the organized and scheduled setting of the clinical trial. Because there are not much data on the cough in relation to telmisartan, therefore it would we worth to observe the cough frequency and general treatment tolerance in patients treated with telmisartan, who had to stop their previous ACE-I treatment due to cough.

Inclusion Criteria
- Hypertension
 - Age > 18
 - ACE-I related cough
Exclusion Criteria
- Current treatment with telmisartan
 - Cholestatic disorders and severe hepatic failure
 - Allergy to telmisartan 
 - Pregnancy and lactation period

Trial Summary

Enrollment Goal
980
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Slovakia

Status
Completed
 

Trial Design